Breast Cancer Helpline 888.753.5222 Living Beyond Breast Cancer LBBC Homepage

African-Americans Breast Cancer Clinical Trials

Current Clinical Trials

| Share

7/7/2010

Trial May Advance Personalized Medicine

If you are newly diagnosed, find out whether you are eligible to participate in I-SPY2, a trial measuring the effectiveness of adding new medicines to standard chemotherapy given before surgery. Read more ...

6/1/2007

Trial Examines Optimal Treatments for HER2-Positive Early Breast Cancer

Phase III trial will compare lapatinib and trastuzumab in preventing recurrence of early-stage breast cancer after surgery and chemotherapy. Read more ...

6/1/2007 through 6/1/2014

Researchers Test Safety and Effectiveness of New Advanced Breast Cancer Treatment

Phase II trial will compare paclitaxel plus sorafenib to paclitaxel alone in women with locally recurrent or metastatic breast cancer Read more ...

10/1/2006

Trial Examines Value of Circulating Cancer Cells in Advanced Cancer

Trial studies whether women with high levels of circulating tumor cells who switch medicines after their first chemotherapy treatment live longer than those who do not Read more ...

8/1/2006

Sexual Well-Being and Breast Cancer Study for Women who Partner with Women

Boston University researchers seek lesbians, bisexual women and women who partner with women who have or have not had breast cancer to complete a survey about sexual well-being Read more ...

6/30/2006

Trial to Investigate Benefits of Education and Exercise for Lymphedema

Researchers seek women newly diagnosed with stage I-III breast cancer planning to undergo axillary lymph node dissection for a study on preventing and treating lymphedema Read more ...

2/1/2004

Study Examines Impact of Exemestane on High-Risk Women

Study compares exemestane to placebo in high-risk women to see whether an aromatase inhibitor lessens the risk of developing invasive breast cancer. Read more ...

Ongoing

Trial for Young Women Studies Effectiveness of Goserelin to Prevent Early Menopause

A randomized phase III clinical trial for young women with stage I-IIIA hormone receptor-negative breast cancer compares the effectiveness of ovarian suppression using goserelin combined with chemotherapy versus chemotherapy alone in preventing early menopause. Read more ...

Top of Page